This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
Satyin Kaura, MSci, MBA
Advertisement
Articles by Satyin Kaura, MSci, MBA
Advertisement
Latest Updated Articles
- The Value of Survival Gains in Myelodysplastic Syndromes
January 16th 2017
Advertisement
Advertisement
Trending on AJMC
1
Patient Portal Messages Outpace Office Visits
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
4
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
5